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Adeno-associated virus (AAV), a common genital virus, may have a “protective” role against human papillomavirus
(HPV)-associated cervical cancer. Epidemiological studies indicate a negative correlation between AAV infection and the
incidence of cervical cancer. In contrast, HPV is positively associated with cervical cancer. To investigate interactions
between these two viruses we used the organotypic “raft” culture system. The raft culture system is capable of supporting
the complete HPV life cycle. Raft tissues that were actively replicating HPV were superinfected with AAV type 2 (AAV-2). We
observed a multiplicity of infection (m.o.i.)-dependent enhancement and inhibition of HPV DNA replication, concomitant with
AAV-2 replication. The data suggest that at low m.o.i. of AAV-2 infection, HPV DNA replication was slightly increased
compared to controls and AAV-2 replicated poorly. At high AAV-2 m.o.i., HPV DNA replication was reduced and AAV-2
replicated to high levels. AAV-2 replication was increased in the presence of HPV compared to primary human keratinocyte,
squamous cell carcinoma, and HaCat raft cultures infected with AAV-2 alone. These data suggest that HPV may provide types
of “enhancer/helper” functions for AAV-2 replication and progeny formation. Infection with AAV-2 had significant effects on
epithelial morphology. During infection with low m.o.i. of AAV-2 the epithelium stratified to a greater extent than in controls.
With high m.o.i. of AAV-2 infections, tissue cytopathic effects were observed, indicating an additional factor responsible for
the effect of AAV-2 on HPV replication and infection. Our results demonstrate a complex interaction between AAV-2, HPV, and
skin during dual infection. © 2001 Academic PressINTRODUCTION
Epidemiological and laboratory studies suggest that
adeno-associated virus (AAV) may have an inhibitory
effect against the development of human papillomavirus
(HPV)-associated cervical cancer (Coker et al., 2001;
Georg-Fries et al., 1984; Hermonat, 1989, 1992, 1994;
Mayor et al., 1976; Schmitt et al., 1989). HPV is positively
associated with over 90% of all cervical cancers exam-
ined and is considered the most important risk factor
(DiMaio, 1991; Pfister, 1990; Syrjanen et al., 1987; Wer-
ness et al., 1991; zur Hausen, 1991). HPVs induce neo-
plastic epithelial lesions in vertebrate animals, including
humans (Broker and Botchan, 1986; zur Hausen and
Schneider, 1987). Subsets of HPVs have been identified
which are associated with malignant neoplasias of the
anogenital region, particularly the cervix (Boshart et al.,
1984; de Villiers, 1989; Durst et al., 1983; Parkin et al.,
1993; Pfister, 1987). AAV is a highly prevalent genital virus
(Han et al., 1996; Tobiasch et al., 1994). However, in
contrast to HPV, AAV has been traditionally described as
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30a nonpathogenic, helper-dependent parvovirus, which
replicates and produces progeny virus only in the pres-
ence of another virus, such as adenovirus (Casto et al.,
1967), herpes simplex virus (Buller et al., 1981), and pox
virus (Schlehofer et al., 1986). AAV receives “helper func-
tions” from the helper virus, thus allowing AAV replication
and in return AAV inhibits the DNA replication (Bantel-
Schaal and zur Hausen, 1987; Carter et al., 1979) and
oncogenicity (Blacklow et al., 1978; Cukor et al., 1975; de
la Maza and Carter, 1981; Ostrove et al., 1981) of the
helper virus.
Epidemiological studies indicate a significant negative
association between AAV infections and cervical cancer.
A study conducted by Mayor et al. demonstrated that
while 85% of normal controls were seropositive for AAV
types 2/3, only 14% of patients with genital cancer were
positive (Mayor et al., 1976). A second study by George-
Fries et al. found that control patients had threefold
higher antibody titers against AAV type 5 than patients
with cervical cancer (George-Fries et al., 1984). Elevated
antibody titers are indicative of viral challenge and there-
fore suggest the idea that AAV infections may provide
natural protection against HPV-associated malignant
progression. A recent study in which the association of
AAV with CINIII and HPV was analyzed by polymerase
chain reaction amplification also supports this conclu-
sion (Coker et al., 2001). These studies have led us to
31INTERACTION BETWEEN AAV AND HPVhypothesize that AAV’s negative association with cervical
cancer may be due to its ability to inhibit HPV replication
and oncogenic potential (Hermonat, 1989).
A series of studies consistent with this hypothesis,
that AAV may have a negative effect on papillomavirus
replication and oncogenicity, has been published (Her-
monat, 1989, 1992). These studies utilized the bovine
papillomavirus (BPV) as a prototype papillomavirus.
When AAV and BPV genomic DNAs were cotransfected
into contact-inhibited C127 cells, BPV-induced oncogenic
transformation was inhibited by almost 99% (Hermonat,
1989). Genetic studies showed that the AAV Rep78 pro-
tein was responsible for this inhibition via the BPV p89
promoter. It was also observed that the AAV Rep78 pro-
tein was able to limit BPV-1 DNA replication (Hermonat,
1992). Finally, AAV could also strongly inhibit HPV16-
induced oncogenic transformation (Hermonat, 1994). The
AAV Rep78 protein was responsible for AAV’s inhibition
of HPV16 at least in part by inhibiting activity of the p97
promoter of HPV16 (Hermonat et al., 1997b) and direct
binding to sequences of this promoter (Zhan et al., 1999).
The studies examining the effect of AAV on BPV and
HPV were performed in monolayer cell culture systems,
usually in mouse fibroblasts, which are incomplete for
the productive papillomavirus life cycle. In order to better
understand the interaction between HPV and AAV, a cell
culture system which is productive for both viruses is
necessary. We have previously reported the utility of the
organotypic “raft” culture system to support indepen-
dently the complete differentiation-specific replication
cycle of HPV (Meyers et al., 1992, 1997) and AAV (Meyers
et al., 2000). This type of a culture system provides a
unique and relevant tool with which to investigate the
interaction of HPV and AAV and further analyze the rela-
tionship between these two anogenital viruses. We
demonstrate that AAV infection can both positively and
negatively affect HPV replication in a m.o.i.-dependent
manner. In contrast, AAV replication increases in a m.o.i.-
dependent manner. AAV replicates and produces infec-
tious progeny virions in the presence of HPV, demon-
strating that HPV provides necessary helper/enhancer
functions. Additionally, AAV infection stimulates tissue
stratification at low m.o.i., inducing extreme cytopathic
effects at high m.o.i.
RESULTS
AAV-2 infection and HPV replication
We investigated AAV-2 and HPV31b co-infections in
raft culture tissue which duplicates normal epithelial
growth and differentiation. The CIN-612 9E is a biopsy-
derived cell line from a low-grade cervical neoplastic
lesion which maintains episomal copies of HPV31b (Be-
dell et al., 1991). When grown in raft cultures the CIN-612
9E cell line duplicates the complete HPV life cycle, in-
cluding production of infectious viral particles (Meyers etal., 1992). Infection of CIN-612 9E raft cultures with AAV-2
using a m.o.i. of 0.1, 1, 5, 50, or 100 affected the replication
of HPV DNA in an m.o.i.-dependent manner (Fig. 1). AAV
m.o.i. of 0.1 and 1 modestly increased the HPV copy
number compared to mock-infected raft tissue (Fig. 1A,
compare lanes 2, 4, and 6, and Fig. 1B). In contrast, using
an AAV m.o.i. of 5 the HPV31b copy number was similar
FIG. 1. AAV-2 m.o.i.-dependent increase and decrease of HPV 31b
genome replication. (A) Southern blot hybridization of total DNA iso-
lated from AAV-infected CIN-612 9E raft cultures. 5 mg of total DNA was
electrophoresed on a 0.8% agarose gel and transferred to nylon mem-
brane, followed by hybridization with a HPV31b-specific probe. Even-
numbered lanes of each m.o.i. tested were XbaI digested. XbaI linear-
izes HPV31b DNA. Odd-numbered lanes of each m.o.i. tested consist of
uncut DNA. Lanes 1 and 2, mock-infected raft. Lanes 3 and 4, AAV m.o.i.
0.1. Lanes 5 and 6, AAV m.o.i. 1. Lanes 7 and 8, AAV m.o.i. 5. Lanes 9 and
10, AAV m.o.i. 50. Lanes 11 and 12, AAV m.o.i. 100. FI (form I) indicates
supercoiled DNA, FII (form II) indicates nicked circular DNA, and FIII
(form III) indicates linearized DNA. (B) Densitometric analysis of the
results in A. For quantification, Form III bands at each of the m.o.i. of
AAV were scanned from three individual experiments.to mock-infected tissue (Fig. 1A, lane 8, and Fig. 1B).
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32 MEYERS ET AL.Finally, at AAV m.o.i. of 50 and 100, HPV copy number
was greatly decreased (Fig. 1A, lanes 10 and 12, and Fig.
1B). We have repeated this experiment several times
with reproducible results. The cumulative results of three
such independent experiments are shown in Fig. 1B.
These data strongly suggest that AAV-2 can induce a
negative and a positive effect at the level of HPV DNA
replication in a m.o.i.-dependent manner.
AAV-2 DNA replication and virion production
AAV is described as a helper-dependent parvovirus
which utilizes helper functions from other viruses which
support AAV DNA replication and progeny virus forma-
tion. In turn, AAV inhibits replication of its helper virus.
However, we now know that AAV has a basal level of
autonomous replication in a skin model (Meyers et al.,
2000). AAV-2 has a 4.7-kb single-stranded genome that
encodes three capsid proteins and four regulatory pro-
teins (Rep). During a productive infection the incoming
AAV single-stranded DNA is converted into a double-
stranded monomeric duplex of 4.7 kb referred to as a
“replicative intermediate” (for review, see Ferrari et al.,
1996; Fisher et al., 1996). This replicative intermediate is
indicative of active AAV genome replication. We were
interested in determining if HPV could provide enhancer/
helper virus functions for AAV-2 replication. Five micro-
grams of Hirt DNA, taken from CIN-612 9E rafts infected
with different m.o.i. of AAV, was used for Southern blot
analysis using an AAV-2-specific probe. The AAV-2 rep-
licative monomer duplex of 4.7 kb was easily detectable
only at 100 m.o.i. of AAV infection (Fig. 2, lane 6). At
FIG. 2. HPV31b is able to serve as a complete helper for AAV progeny
production in raft cultures. Southern blot hybridization of DNA isolated
from AAV-2-infected CIN-612 9E rafts grown in the presence of the PKC
activator C8. 5 mg of Hirt DNA from raft cultures treated with AAV as in
ig. 1 was electrophoresed in a 0.8% agarose gel, transferred to
embrane, and probed with AAV-2-specific DNA probes. The replica-
ive monomer intermediate of 4.7-kb duplex and the single-stranded
ss) DNA of AAV-2 are indicated.longer exposures this monomer duplex was evident atthe lower m.o.i. used (data not shown). To more readily
detect low levels of progeny AAV-2 virion synthesis in the
raft tissues at the low m.o.i. of AAV, we utilized the
second-plate amplification method (Fig. 3). Putative
AAV-2 stocks generated from AAV-2-infected raft tissues
were added to a second plate of adenovirus-preinfected
293 cells. Hirt DNA was isolated from the plates at 36 h
postinfection, Southern blotted, and detected with an
AAV-2-specific probe. AAV-2 DNA replication and virion
synthesis were amplified severalfold and were easily
detectable at all initial AAV m.o.i. of 1 and above used to
infect CIN-612 9E raft tissues (compare Figs. 2 and 3).
Upon prolonged exposure AAV DNA was also detected
at AAV m.o.i. of 0.1 (data not shown). Therefore, the
progeny AAV-2 virions isolated from the raft cultures are
not defective in their ability to infect the 293 monolayer
cells. These results also rule out the possibility that
AAV-2 DNA replication occurred in the absence of infec-
tious particle production. The increase in AAV-2 DNA
synthesis and infectivity in the second-plate amplifica-
tion (Fig. 3) is consistent with the idea that AAV-2 is not
latent but replicates even at the low m.o.i.
Interestingly, on one hand, our results show that HPV
replication is enhanced at low AAV m.o.i. (Fig. 1), accom-
panied by AAV replication (Fig. 3). On the other hand, at
high AAV m.o.i. HPV31b replication is greatly inhibited,
concurrent with high levels of infectious AAV-2 replica-
tion and synthesis (Figs. 1 and 3). These results demon-
strate that at low to medium AAV m.o.i., coexistence of
both viruses is possible, but inhibition of HPV by AAV-2 is
observed at high m.o.i. These results are consistent with
the idea that HPV31b can provide enhancer/helper func-
FIG. 3. Second-plate amplification of AAV-2. AAV-2-infected CIN-612
9E epithelial cells were harvested on day 12, freeze–thawed in medium
several times as described, and used as a source of putative AAV-2
viral stock. AAV-2 viral stocks were used to infect 293 cells preinfected
with adenovirus. The 293 cells were harvested at 36 h and used for
total DNA extraction and Southern blot analysis using probes specific
for AAV-2 DNA. The 4.7-kb replicative monomer intermediate is indi-
cated. The 9.4-kb band is the replicative form dimer. Single-stranded
(ss) DNA is indicated.
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33INTERACTION BETWEEN AAV AND HPVtions for AAV-2 replication resulting in the synthesis of
infectious AAV-2 virion particles.
HPV provides enhancer functions for AAV-2
replication and virion production
Our results suggest a bidirectional interaction be-
tween HPV31b and AAV-2. We have previously demon-
strated that AAV-2 is capable of autonomous replication
and virion production in fully differentiated primary HFK
raft cultures (Meyers et al., 2000). We therefore wanted to
determine if the helper functions are due to HPV repli-
cation or are due to differentiation of the epithelium.
Primary HFK and CIN-612 9E raft tissues were prepared
using 106 cells per raft culture. In this case a higher
number of cells were used because HFK raft cultures
grow poorly at lower densities. The primary HFK cells
were devoid of HPV or any other known helper virus, as
previously demonstrated (Meyers et al., 2000). Both types
of raft cultures were infected with increasing AAV m.o.i.
as described. On day 12, raft tissues were harvested and
used for the extraction of Hirt DNA and used to perform
Southern blot analysis with an AAV-2-specific probe (Fig.
4). AAV-2 replication was augmented or enhanced in the
presence of HPV31b to a greater extent than when HFK
raft cultures were infected with AAV-2 alone (Fig. 4). The
progeny AAV-2 virions from the HFK rafts are infectious
and correlate with the AAV-2 genome replication (Meyers
FIG. 4. Enhancement of AAV-2 replication in the presence of HPV31b
evoid of helper virus. 106 epithelial cells were seeded onto each type
f Hirt DNA from raft was electrophoresed in a 0.8% agarose gel, tr
eplicative monomer intermediate of the 4.7-kb duplex of AAV-2 is indica
NA is indicated.et al., 2000). Our results strongly suggest that HPV31b Acan enhance AAV-2 replication and virion production by
providing a set of helper functions.
We further wanted to demonstrate that the results from
the second-plate amplification experiment (Fig. 3), which
is indicative of infectious AAV-2 synthesis, were not an
artifact due to carryover of AAV-2 particles used to infect
the CIN612-9E raft cultures. Therefore, we performed
identical experiments in which HaCat and SCC raft cul-
tures were infected with AAV-2. It has been previously
demonstrated that monolayer cultures of HaCat cells do
not support AAV replication (Klein-Bauernschmitt et al.,
1992). HaCat (Schoop et al., 1999) and SCC (McCance et
l., 1988) cells have demonstrated different levels of
ifferentiation capabilities in raft cultures. Both HaCat
nd SCC raft cultures were shown to weakly support
AV-2 replication (Fig. 4) as evidenced by the small level
f the 4.7-kb replicative monomer which was detectable
fter prolonged exposures (data not shown). We per-
ormed second-plate amplification of putative AAV stocks
rom HaCat and SCC raft cultures. In the second-plate
mplification experiments both HaCat and SCC raft cul-
ures also showed lower levels of AAV replication com-
ared to HFK raft cultures (data not shown), which is
herefore consistent with the results in Fig. 4. The differ-
nces between the CIN-612 9E, the HFK, the HaCat, and
he SCC raft cultures in supporting AAV-2 replication and
nfectious particle production negate the idea that the
12 9E raft cultures in comparison to HFK, SCC, and HaCat raft cultures
t culture and infected with m.o.i. of 50 or 100 AAV as described. 5 mg
ed to membrane, and probed with AAV-2-specific DNA probes. The
e 9.4-kb band indicates the replicative form dimer. Single-stranded (ss)in CIN-6
of raf
ansferr
ted. ThAV-2 replication observed in the second-plate amplifi-
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34 MEYERS ET AL.cation experiments is an artifact due to carryover of
AAV-2 particles. Additionally, AAV-2 particles do not sur-
vive for prolonged periods in culture. Finally, we have
performed control experiments in which monolayer CIN-
612 9E cells were trypsinized after AAV-2 infection before
use in raft cultures. Trypsin-pretreated raft cultures were
able to support the dual replication of both HPV and AAV
(data not shown). This trypsinization should effectively
eliminate any chance of significant surviving external
AAV virus.
We also compared the ability of CIN-612 9E monolayer
cultures to support AAV-2 replication to that of AAV-2-
infected CIN-612 9E raft cultures. AAV-2 replication oc-
curred in monolayer cultures but was greatly lower com-
pared to that in all the raft cultures tested (Fig. 4). The
4.7-kb replicative intermediate was visible upon overex-
posure. The ability of monolayer cell cultures to support
AAV replication has been recently reported (Ogston et al.,
2000), although it is notable that m.o.i. of between 2 3
103 and 5 3 103 were required to observe AAV replica-
ion.
ffect of AAV infection on tissue morphology
Raft tissue morphology was used to analyze the im-
act of AAV/HPV interaction. CIN-612 9E raft cultures
nfected with AAV-2 using m.o.i. of 0.1, 1, 5, 50, and 100
ere harvested on day 12. Raft tissues were formalin
ixed, paraffin embedded, thin sectioned, and H&E
tained for histologic analysis. Multiple random sections
rom three or four rafts were examined and showed that
pithelia infected with 0.1 and 1 m.o.i. of AAV demon-
trated thickening in contrast to mock-treated raft tissues
FIG. 5. H&E staining and histological analysis of the impact of AAV-
ifferentiation at increasing m.o.i. of AAV-2 infection. (A) Cross section
PV31b and AAV, m.o.i. 1. (D) HPV31b and AAV, m.o.i. 5. (E) HPV31b aHPV31b alone) (compare Figs. 5A, 5B, and 5C). At m.o.i. if 5 AAV (Fig. 5D) the epithelium showed a dramatic
eduction in thickness comparable to that of the 0.1- and
-m.o.i.-infected tissues. At m.o.i. of 5 AAV the level of
rowth and tissue stratification was intermediate to that
etween the lower and the higher m.o.i. used and prob-
bly indicates the lytic activity of AAV (Fig. 5D). At m.o.i.
f 50 and 100 the ordered stratification of the epithelium
as destroyed and the epithelium showed the hallmarks
f tissue cytopathic effects (Figs. 5E and 5F). The cyto-
athic effects apparent at m.o.i. of 50 and 100 AAV
nfection (Figs. 5E and 5F) readily correlate with high
evels of AAV-2 replication in the raft tissues (Figs. 2
nd 3).
estern immunoblot analysis
AAV has been shown to enhance the expression of
ifferentiation markers such as keratin-10 and involucrin
n monolayer cell cultures (Klein-Bauernschmitt et al.,
992). The ability to drive cell-cycle processes toward
reater terminal differentiation is thought to be one of the
echanisms by which AAV exerts its oncosuppressive
roperties (Bantel-Schaal, 1995). On the other hand, HPV
eplication and infectious virion production are greatly
ependent on cellular differentiation. Concurrently, AAV
elper-independent replication is differentiation depen-
ent (Fig. 4 and Meyers et al., 2000). We wanted to
etermine whether the increase in HPV replication (Fig.
) and increased tissue thickening (Figs. 5B and 5C) at
ow m.o.i. of AAV infection correlated with an increase in
he expression of differentiation markers. Total protein
xtracts from CIN-612 9E raft tissues were used for
erforming Western immunoblot analysis using antibod-
1b interaction in raft cultures. Significant changes in morphology and
k-infected 9E raft with HPV31b only. (B) HPV31b and AAV, m.o.i. 0.1. (C)
, m.o.i. 50. (F) HPV31b and AAV, m.o.i. 100.2/HPV3
of moc
nd AAVes against involucrin, keratin-14, keratin-10, and filag-
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35INTERACTION BETWEEN AAV AND HPVgrin. All proteins are markers of epithelial differentiation
(for review see Chow and Broker, 1997). Additionally,
keratin-10, keratin-14, and filaggrin expressions were
lower at AAV m.o.i. of 0.1 compared to control and pro-
gressively decreased with increasing AAV m.o.i. (Fig. 6).
In comparison, involucrin expression remained constant
regardless of the m.o.i. of AAV infection (Fig. 6). There-
fore, in general, the results of the Western immunoblot
analysis (Fig. 6) show a decrease, rather than an in-
crease, in the expression of differentiation markers with
increasing m.o.i. of AAV infection. Taken together with
the Southern blot analysis (Fig. 1), these data suggest
that the modest increase in HPV replication at low AAV
m.o.i. of infection (Fig. 1) was not an indirect result of
accelerated tissue differentiation but most probably was
due to a direct effect of AAV proteins on HPV replication.
DISCUSSION
AAV and HPV are both genital viruses (Boshart et al.,
1984; Tobiasch et al., 1994), AAV being nonpathogenic
Georg-Fries et al., 1984; Mayor et al., 1976) and HPV
eing associated with human cervical cancer (DiMaio,
991; Pfister, 1990; Syrjanen et al., 1897; Werness et al.,
991; zur Hausen, 1991). Epidemiological studies indi-
ate that AAV infection is negatively associated with
igh-grade lesions and cervical cancer (Coker et al.,
001; Georg-Fries et al., 1984; Mayor et al., 1976). To
etermine how AAV may elicit its “protective” effect on the
FIG. 6. Western immunoblot analysis of the expression of differenti-
ation markers involucrin, keratin-14, keratin-10, and filaggrin. Total
protein was extracted from AAV-infected raft cultures as described
under Materials and Methods and resolved on a 10% SDS–PAGE gel.
Western blotting with the indicated antibodies was performed as de-
scribed under Materials and Methods.arly stages of HPV infection and associated cancer weinvestigated the effect of AAV-2 superinfection on HPV
replication. Using the organotypic raft culture system we
demonstrated that AAV-2 has multiple apparent effects
on HPV replication depending on the m.o.i. of AAV-2
used. At infection levels at which AAV-2 replication is low,
HPV replication is stimulated. Therefore under these
conditions, coexistence of both viruses is possible. How-
ever, at high m.o.i., at which AAV-2 replicates to high
levels, HPV replication is simultaneously inhibited. The
ability of AAV-2 to inhibit HPV31b replication is significant
because it supports the negative correlation with HPV-
induced cervical cancer in the presence of AAV. We
hypothesize that the negative effect of AAV-2 on HPV
replication is consistent with the correlation between
AAV seropositivity and cervical cancer.
The positive effect on HPV31 replication at low m.o.i. of
AAV-2 infection may be due to an unknown mechanism
whereby low levels of AAV Rep proteins expressed may
enhance HPV31b DNA replication. On the other hand, at
high m.o.i. of AAV-2 infection, abundant Rep protein ex-
pression may be predicted to have the inhibitory effect
on HPV31 replication. We also cannot rule out the pos-
sibility that the inhibition of HPV31 replication is due to
the cytopathic effects caused by the lytic nature of AAV-2.
CIN-612 9E raft cultures infected with herpes simplex
virus types 1 and 2 give rise to similar cytopathic effects
but do not inhibit HPV31 replication (Andreansky and
Meyers, unpublished observations). Rep78 has the dual
ability to both positively and negatively autoregulate ex-
pression from its own promoters (Labow et al., 1986). The
AAV-encoded Rep78 protein has been shown to inhibit
the oncogenic transformation of both BPV (Hermonat,
1989) and HPV16 (Hermonat et al., 1997b; Zhan et al.,
1999) via interaction with specific promoters. Rep78,
Rep68, and Rep52 proteins can also down regulate gene
expression from heterologous promoters, which do not
contain Rep binding motifs (Rittner et al., 1992; Batchu
and Hermonat, 1995; Kokorina et al., 1998). It is not
known how the Rep proteins act as repressors on het-
erologous promoters. However, binding to Sp1 (Her-
monat et al., 1996) and to components of the basal
transcription machinery or accessory factors (Horer et
al., 1995) may play a role. Rep78 has been shown to
disrupt binding of TBP to the HPV16 p97 promoter, sug-
gesting an indirect effect of Rep78 on HPV promoter
expression (Su et al., 2000). Recent yeast two-hybrid
screens and in vitro studies suggest that Rep78 may
interfere with normal cyclic AMP response pathways in
AAV-infected cells (Chiorini et al., 1998; di Pasquale and
Stacey, 1998). Two-hybrid studies have implicated that
the Rep78 C-terminal domain binds to PRKX, a homolog
of the protein kinase A (PKA) catalytic subunit (Chiorini et
al., 1998; di Pasquale and Stacey, 1998), which was
shown to undergo autophosphorylation and demon-
strated kinase activity toward a PKA oligopeptide target
(di Pasquale and Stacey, 1998). Binding to Rep78 inhib-
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36 MEYERS ET AL.ited autophosphorylation and kinase activity of PRKX.
PRKX also mediated CREB-dependent transcription,
which was suppressed by Rep78 but not Rep68 (di Pas-
quale and Stacey, 1998). We have found that the pres-
ence or absence of protein kinase C activators greatly
affects the ability of AAV to inhibit HPV replication (Alam
and Meyers, unpublished observations). We hypothesize
that the complex interaction of HPV31b and AAV may
affect the normal balance of kinase-activated cell signal-
ing pathways and subsequent virion production by both
HPV31b and AAV-2.
AAV has been classified as a typical Dependo-virus
which is unable to replicate in the absence of other
viruses which can provide helper functions. AAV obtains
helper functions from another virus and in turn inhibits
helper virus replication. In this study the interaction ob-
served between HPV and AAV is reminiscent of similar
interactions observed between AAV and adenovirus
(Casto et al., 1967), poxvirus (Schlehofer et al., 1986), and
herpesvirus (Buller et al., 1981). More recently, however,
we have determined that AAV is also capable of under-
going autonomous replication in the primary raft cultures
and therefore is not a strict helper-dependent virus (Mey-
ers et al., 2000). In the current study, AAV-2 replicated to
high titers in the presence of HPV31b, which presumably
provides “enhancer” functions. Thus, AAV has the dual
ability to undergo enhanced replication and autonomous
replication.
To categorize HPV31b as a true enhancer virus it was
necessary to compare the magnitude of AAV replication
in the presence and absence of HPV31b. Previous to this
study, Walz et al. (1997) has reported that HPV16-positive
ells can support AAV replication. In our study, HPV
reatly enhances the replication of AAV compared to
xperiments in which AAV infections were performed on
rimary HFK raft cultures in the absence of any other
irus (Meyers et al., 2000) as well as HaCat and SCC raft
ultures. Therefore, the CIN-612 9E raft cultures are ca-
able of supporting the complete life-cycle of both
PV31b and AAV-2, with HPV31b providing enhancer
unctions for AAV-2 replication. However, as in autono-
ous AAV replication in differentiating rafts composed of
ormal keratinocytes, AAV replication in HPV31b-con-
aining rafts is still dependent upon cellular differentia-
ion.
The AAV–HPV interaction causes dramatic alteration
n skin tissue morphology. At low m.o.i. of AAV tissue
tratification is pronounced compared to control, with
xtreme cytopathic effects produced at high m.o.i. of
AV-2. We observed a host of effects ranging from pro-
ounced stratification, lysis, and cytopathic effects de-
endent on the AAV m.o.i. used. Previously reported
tudies suggest that AAV has the potential to positively
ffect the differentiation program of cells (Klein-Bauern-
chmitt et al., 1992). This fact could be used to explainhe increased stratification of tissues observed at lowAAV-2 m.o.i. Our Western immunoblot results clearly
show that keratin-10, keratin-14, and filaggrin expression
decreases significantly at the lowest m.o.i. of 0.1 AAV,
whereas involucrin expression was unaffected. How-
ever, it should be pointed out that the Klein-Bauern-
schmitt results were derived from cells grown as a sub-
merged monolayer and not derived from a raft culture
system. We believe that it is most likely that the cyto-
pathic effect seen is a result of the cells infected with
AAV stratifying in the raft culture and then lysing after
stratification and differentiation are almost complete.
AAV is a ubiquitous anogenital virus and is believed to
be devoid of any cytopathology. We observed that at low
AAV-2 m.o.i. HPV replication is increased compared to
controls. From this finding it could be speculated that
HPV-infected patients who are also infected with AAV
may actually carry a higher than average HPV load. At
high AAV-2 m.o.i. HPV replication is significantly de-
creased but at the same time is associated with signifi-
cant tissue cytopathology.
Our results in the current study strongly support the
early epidemiological data (Georg-Fries et al., 1984;
Mayor et al., 1976) and the more recent study by Coker et
al. (2001) which suggested that seropositivity for AAV is
negatively correlated with HPV-associated cervical can-
cer. We demonstrated that at high AAV m.o.i., HPV repli-
cation is significantly decreased and is concurrent with
high levels of AAV replication and virion production. Our
results are significant given that both AAV and HPV are
anogenital viruses and appear to coexist under normal
physiological conditions. Cervical biopsies have previ-
ously been shown to contain colocalized HPV16 and
AAV2 DNA (Walz et al., 1997). In fact, AAV type 5 was
initially isolated from a low-grade penile condylomatous
lesion (Georg-Fries et al., 1984). Our results emphasize
the effect of AAV on HPV replication and keratinocyte
differentiation in the early stages of HPV infection and
tumorigenesis. However, the effect of AAV on later
stages of invasive carcinoma has yet to be determined.
MATERIALS AND METHODS
Organotypic epithelial raft cultures and AAV
viral infections
The CIN-612 cell line was established from a cervical
intraepithelial neoplasia (CIN) type I biopsy and contains
HPV31b DNA (Bedell et al., 1991). The CIN-612 9E clonal
derivative maintains episomal copies of HPV31b genome
at approximately 50 copies per cell (Bedell et al., 1991).
Human foreskin keratinocytes (HFKs) were purchased
from Clonetics (Walkersville, MD). CIN-612 9E cells were
maintained in monolayer culture with E medium contain-
ing 5% fetal bovine serum in the presence of mitomycin
C-treated J2 3T3 feeder cells (McCance et al., 1988;
Meyers, 1996). HFKs were maintained in monolayer cul-
tures without feeder cells, with KGM-2 medium (Clonet-
n
s
9
a
r
t
r
e
o
L
c
l
a
1
i
N
m
i
(
c
t
b
f
N
r
H
p
1
1
r
s
b
r
i
S
m
t
s
A
t
p
3
a
r
f
H
i
4
s
s
W
p
c
m
T
s
r
m
1
37INTERACTION BETWEEN AAV AND HPVics). After lifting to the air–liquid interface, HFK raft cul-
tures were maintained in E medium. The SCC
(HPV-negative squamous cell carcinoma) and HaCat
(spontaneously immortalized) cell lines were maintained
in monolayer cultures with E medium. Organotypic raft
cultures were generated as has been previously de-
scribed (Meyers et al., 1992, 1997) with the following
differences. CIN-612 9E raft cultures were made by seed-
ing 2 3 105 cells on top of the collagen matrices. The
ext day medium was removed. AAV-2 viral stocks were
erially diluted in E medium and placed on top of CIN-612
E cells. AAV-2 multiplicities of infection of 0.1, 1, 5, 50,
nd 100 were used to infect the raft cultures. Plates were
ocked every 15 min for 2 h. Medium was replaced onto
he rafts and incubated overnight. Starting the next day,
aft cultures were lifted to the air–liquid interface and fed
very other day with E medium plus 10 mM 1,2-di-
ctanoyl-sn-glycerol (C8:0) (Sigma Chemical Co., St.
ouis, MO), a PKC inducer, for a total of 12 days. These
onditions have been shown to be optimal for HPV rep-
ication and production of infectious progeny (Meyers et
l., 1992; Ozbun and Meyers, 1996, 1997; 1998a). On day
2 the CIN-612 9E raft cultures were harvested by remov-
ng the epithelial layer and stored at 270°C.
ucleic acid extraction and Southern blotting
AAV-2 and HPV31b viral replication in raft cultures was
easured by Southern blot analysis. Total cellular DNA
n raft tissue was extracted as previously described
Ozbun and Meyers, 1998b). Five micrograms of total
ellular DNA was digested with XbaI, which linearizes
he HPV31b genome at nucleotide 4998, and separated
y 0.8% agarose gel electrophoresis followed by trans-
erring to GeneScreen Plus membranes (New England
uclear Research Products, Boston, MA), as previously
eported (Ozbun and Meyers, 1998b). A 32P-labeled total
PV31b genomic DNA probe was generated by random
rimer extension as described (Ozbun and Meyers,
998b). For detecting AAV-2 DNA, 5 mg of Hirt DNA was
isolated as previously described (Hermonat et al., 1997a,
984) and was similarly electrophoresed on a 0.8% aga-
ose gel, followed by transferring to membrane as de-
cribed for HPV31b. Samples were probed with 32P-la-
eled total AAV-2 genomic DNA probe generated by
andom primer extension using plasmid pSSV9 linear-
zed with PvuII.
econd plate amplification
On day 12 raft tissues were harvested and minced, 1
l of medium was added, and the cells were freeze-
hawed three times to generate a putative AAV-2 virus
tock. Equal aliquots from each of the different m.o.i.
AV-2-infected and mock-infected rafts were DNase
reated and transferred onto a second plate of 293 cells
reincubated with adenovirus. Hirt DNA was isolated at n6 h postinfection as previously described (Hermonat et
l., 1997a, 1984). Five micrograms of Hirt DNA was aga-
ose gel electrophoresed, Southern blotted, and probed
or AAV-2 sequences.
istochemical analysis
Raft cultures were grown for 12 days, harvested, fixed
n 10% buffered formalin, and embedded in paraffin and
-mm cross sections were prepared. Sections were
tained with hematoxylin and eosin as previously de-
cribed (Meyers et al., 1992).
estern immunoblot analysis
Total protein extracts were prepared as described
reviously (Sil et al., 2000) but modified to manipulate raft
ulture tissues. Individual raft tissue samples were ho-
ogenized in 350 ml Buffer A (50 mM NaPO4, pH 7.2, 5
mM EDTA, 50 mM NaF, 0.5 mg/ml leupeptin, 0.5 mg/ml
pepstatin, 20 mg/ml aprotinin, 0.2 mM Na3VO4, 1 mM
DTT, 1 mM PMSF) with 10 strokes using a glass homog-
enizer. Samples were transferred into a 1.5-ml microfuge
tube. Four hundred micrograms of ice-cold acid washed
glass beads (0.45 mm) was added to the samples. Tubes
were placed into a multitube holder and vortexed for
30 s. Samples were then chilled on ice for 30 s. This
procedure was repeated a total of six times. The mi-
crofuge tubes were placed on the rims of 13 3 100-mm
precooled disposable glass tubes. An 18-gauge needle
was used to puncture holes through the lid and bottom of
the microfuge tube. The piggy-back microfuge tube and
glass tube combination was centrifuged to attain a
speed of 2000 rpm and then stopped. The microfuge tube
was discarded. Three hundred fifty microliters of Buffer A
supplemented with 2% (w/v) SDS was added to the
eluted tissue lysate sample in the glass tubes and then
boiled in a water bath for 8 min. While boiling, the
samples were vortexed intermittently every 2 min. Sam-
ples were transferred into a 1.5-ml microfuge tube and
centrifuged for 20 min at room temperature. Five hundred
microliters of the sample was removed and added to 250
ml 53 sample loading buffer (final concentration 100 mM
Tris, pH 8.0, 5 mM EDTA, 10% (w/v) sucrose, 2% (w/v)
SDS, 33 mM DTT, and 0.1 mg/ml Pyronin Y). Total protein
concentrations were measured using the Peterson pro-
tein assay (Lowry method) as previously described (Sil et
al., 2000).
The total protein extracts were used for detecting the
levels of involucrin (30 mg), keratin-14 (60 mg), keratin-10 (10
mg), and filaggrin (60 mg) expression in the raft cultures.
otal protein extracts were applied to a sodium dodecyl
ulfate–8.0% polyacrylamide gel (acrylamide/bisacrylamide
atio, 30/0.8). Proteins were transferred to nitrocellulose
embrane, and the membrane was incubated with keratin-
0-specific monoclonal antiserum (1:1000 dilution) (BioGe-
ix), keratin-14-specific monoclonal antiserum (1:2000 dilu-
38 MEYERS ET AL.tion) (Sigma), involucrin monoclonal antiserum (1:1000 dilu-
tion) (Sigma), and filaggrin-specific monoclonal antibody
(1:200) (BioMedical Technologies, Inc.), overnight. After be-
ing washed, the blots were incubated with anti-mouse
horseradish peroxidase-linked secondary antibody (Amer-
sham Life Science) as per the manufacturer’s instructions.
The proteins were detected by using a chemiluminescence
reagent (Amersham Life Science) as per the manufacturer’s
instructions.
ACKNOWLEDGMENTS
Craig Meyers and Samina Alam contributed equally to the manu-
script. We thank Danuta Huber and Lynn Budgeon for excellent tech-
nical assistance. We thank members of the Meyers and Hermonat
laboratories for critically reading the manuscript and many helpful
discussions. This work was supported by Public Health Service Grant
NIH Grant AI42764 from the National Institute of Allergy and Infectious
Diseases.
REFERENCES
Bantel-Schaal, U. (1995). Growth properties of a human melanoma cell
line are altered by adeno-associated parvovirus type 2. Int. J. Cancer
60, 269–274.
Bantel-Schaal, U., and zur Hausen, H. (1987). Adeno-associated viruses
inhibit SV40 DNA amplification and replication of herpes simplex
virus in SV40 transformed cells. Virology 164, 64–74.
Batchu, R. B., and Hermonat, P. L. (1995). The trans-inhibitory Rep78
protein of adeno-associated virus binds to TAR region DNA of the
human immunodeficiency virus type I long terminal repeat. FEBS
Lett. 367, 267–271.
Bedell, M. A., Hudson, J. B., Golub, T. R., Turyk, M. E., Hosken, M.,
Wilbanks, G. D., and Laimins, L. A. (1991). Amplification of human
papillomavirus genomes in vitro is dependent on epithelial differen-
tiation. J. Virol. 65, 2254–2260.
Blacklow, N. R., Cukor, G., Kibrick, S., and Quinnan, G. (1978). Interac-
tions of adeno-associated viruses with cells transformed by herpes
simplex. In “Replication of Mammalian Parvoviruses” (D. C. Ward and
P. Tattersall, Eds.), pp. 87–97. Cold Spring Harbor Laboratory, Cold
Spring Harbor, NY.
Boshart, M., Gissman, L., Ikenberg, G., Kleinheinz, A., Scheurlen, W.,
and zur Hausen, H. (1984). A new type of papillomavirus DNA, its
presence in genital cancer biopsies and in cell lines derived from
cervical cancer. EMBO J. 3, 1151–1157.
Broker, T. R., and Botchan, M. (1986). Papillomaviruses: Retrospectives
and prospectives. Cancer Cells 4, 17–36.
Buller, R. M., Janik, J. E., Subring, E. D., and Rose, J. A. (1981). Herpes
simplex virus type 1 and 2 completely help adeno-associated virus
replication. J. Virol. 40, 241–247.
Carter, B. J., Laughlin, C. A., de la Maza, L. M., and Meyers, M. (1979).
Adeno-associated virus autointerference. Virology 92, 449–462.
Casto, B. C., Atchinson, R. W., and Hammon, W. McD. (1967). Studies on
the relationship between adeno-associated virus type 1 and adeno-
virus I. Replication of AAV-1 in certain cell cultures and its effect on
helper adenovirus. Virology 18, 52–60.
Chiorini, J. A., Zimmermann, B., Yang, L., Smith, R. H., Ahearn, A.,
Herberg, F., and Kotin, R. M. (1998). Inhibition of PrKX, a novel protein
kinase, and the cyclic AMP-dependent protein kinase PKA by the
regulatory proteins of adeno-associated virus type 2. Mol. Cell. Biol.
18, 5921–5929.
Chow, L. T., and Broker, T. R. (1997). Small DNA tumor viruses. In “Viral
Pathogenesis” (N. Nathanson et al., Eds.), pp. 267–300. Lippincott–
Raven, New York.Coker, A. L., Russel, R. B., Bond, S. M., Pirisi, L., Liu, Y., Mane, M.,Kokorina, N., Gerasimova, T., and Hermonat, P. (2001). Adeno-asso-
ciated virus is associated with a lower risk of high-grade cervical
neoplasia. Exp. Mol. Pathol. 70, 83–89.
Cukor, G., Blacklow, N. R., Kibrick, S., and Swan, I. C. (1975). Effect of
adeno-associated virus on cancer expression by herpesvirus trans-
formed hamster cells. J. Natl. Cancer Inst. 55, 957–959.
de la Maza, L. M., and Carter, B. J. (1981). Inhibition of adenovirus
oncogenicity by adeno-associated virus DNA. J. Natl. Cancer Inst. 67,
1323–1329.
deVilliers, E.-M. (1989). Heterogeniety of the human papillomavirus
group. J. Virol. 63, 4898–4903.
DiMaio, D. (1991). Transforming activity of bovine and human papillo-
maviruses in cultured cells. Adv. Cancer Res. 56, 133–159.
di Pasquale, G., and Stacey, S. N. (1998). Adeno-associated virus Rep78
protein interacts with protein kinase A and its homolog PRKX and
inhibits CREB-dependent transcriptional activation. J. Virol. 72, 7916–
7925.
Durst, M., Gissman, G., Ikenberg, H., and zur Hausen, H. (1983). A
papillomavirus DNA from a cervical carcinoma and its prevalence in
cancer biopsy samples from different geographic regions. Proc. Natl.
Acad. Sci. USA 80, 3012–3015.
Ferrari, F. K., Samulski, T., Shenk, T., and Samulski, R. J. (1996). Second-
strand synthesis is a rate-limiting step for efficient transduction by
recombinant adeno-associated virus vectors. J. Virol. 70, 3227–3234.
Fisher, K. J., Gao, G.-P., Weitzman, M. D., DeMatteo, R., Burda, J. F., and
Wilson, J. M. (1996). Transduction with recombinant adeno-associ-
ated virus for gene-therapy is limited by leading-strand synthesis.
J. Virol. 70, 520–532.
Georg-Fries, B., Bierderlack, S., Wolf, J., and zur Hausen, H. (1984).
Analysis of proteins, helper dependence and seroepidemiology of a
new human parvovirus. Virology 134, 64–71.
Han, L., Parmely, T. H., Keith, S., Kozlowski, K. J., Smith, L. J., and
Hermonat, P. L. (1996). High prevalence of adeno-associated virus
(AAV) type 2 rep DNA in cervical materials: AAV may be sexually
transmitted. Virus Genes 12, 47–52.
Hermonat, P. L. (1989). The adeno-associated virus Rep78 gene inhibits
cellular transformation induced by bovine papillomavirus. Virology
172, 253–261.
Hermonat, P. L. (1992). Inhibition of bovine papillomavirus plasmid DNA
replication by adeno-associated virus. Virology 189, 329–333.
Hermonat, P. L. (1994). Adeno-associated virus inhibits human papillo-
mavirus type 16: A viral interaction implicated in cervical cancer.
Cancer Res. 54, 2278–2281.
Hermonat, P. L., Santin, A. D., and Batchu, R. B. (1996). The adeno-
associated Rep78 major regulatory/transformation suppressor pro-
tein binds cellular Sp1 in vitro and evidence of a biological effect.
Cancer Res. 56, 5299–5304.
Hermonat, P. L., Labow, M. A., Wright, R., Berns, K. I., and Muzyczka, N.
(1984). Genetics of adeno-associated virus: Isolation and preliminary
characterization of mutants in adeno-associated virus. J. Virol. 51,
329–339.
Hermonat, P. L., Quirk, J. G., Bishop, B. M., and Han, L. (1997a). The
packaging capacity of adeno-associated virus (AAV) and its potential
for wild-type-plus AAV gene therapy vectors. FEBS Lett. 407, 78–84.
Hermonat, P. L., Plott, R. T., Santin, A. D., Parham, G. P., and Flick, J. T.
(1997b). The adeno-associated virus Rep78 gene inhibits oncogenic
transformation or primary keratinocytes by a human papillomavirus
type 16-ras chimeric. Gynecol. Oncol. 66, 487–494.
Horer, M., Weger, S., Butz, K., Hoppe-Seyler, F., Geisen, C., and Klein-
schmidt, J. A. (1995). Mutational analysis of adeno-associated virus
Rep protein-mediated inhibition of heterologous and homologous
promoters. J. Virol. 69, 5485–5496.
Klein-Bauernschmitt, P., zur Hausen, H., and Schlehofer, J. R. (1992).
Induction of differentiation-associated changes in established hu-
man cells by infection with adeno-associated virus type 2. J. Virol. 66,
4191–4200.Kokorina, N. A., Santin, A. D., Li, C., and Hermonat, P. L. (1998). Involve-
OO
P
39INTERACTION BETWEEN AAV AND HPVment of protein–DNA interaction in adeno-associated virus Rep78-
mediated inhibition of HIV-1. J. Hum. Virol. 1, 441–450.
Labow, M. A., Hermonat, P. L., and Berns, K. I. (1986). Positive and
negative autoregulation of the adeno-associated virus type 2 ge-
nome. J. Virol. 60, 251–258.
Mayor, H. F., Drake, S., Stahmann, J., and Mumford, D. M. (1976).
Antibodies to adeno-associated satellite virus and herpes simplex in
sera from cancer patients and normal adults. Am. J. Obstet. Gynecol.
126, 100–105.
McCance, D. J., Kopan, R., Fuchs, E., and Laimins, L. A. (1988). Human
papillomavirus type 16 alters human epithelial cell differentiation in
vitro. Proc. Natl. Acad. Sci. USA 85, 7169–7173.
Meyers, C. (1996). Organotypic (raft) culture system for the differentia-
tion-dependent replication of papillomavirus. Methods Cell Sci. 18,
201–210.
Meyers, C., Frattini, M. G., Hudson, J. B., and Laimins, L. A. (1992).
Biosynthesis of human papillomavirus from a continuous cell line
upon epithelial differentiation. Science 257, 971–973.
Meyers, C., Mane, M., Kokorina, N., Alam, S., and Hermonat, P. L. (2000).
Ubiquitous human adeno-associated virus type 2 replicates in dif-
ferentiating keratinocytes of a normal skin model. Virology 272,
338–346.
Meyers, C., Mayer, T. J., and Ozbun, M. A. (1997). Synthesis of infectious
human papillomavirus type 18 in differentiating epithelium trans-
fected with viral DNA. J. Virol. 71, 7381–7386.
Ogston, P., Raj, K., and Beard, P. (2000). Productive replication of
adeno-associated virus can occur in human papillomavirus type-16
(HPV-16) episome-containing keratinocytes and is augmented by the
HPV-16 E2 protein. J. Virol. 74, 3494–3505.
Ostrove, J. M., Duckworth, D. H., and Berns, K. I. (1981). Inhibition of
adenovirus-transformed cell oncogenicity by adeno-associated vi-
rus. Virology 113, 521–533.
Ozbun, M. A., and Meyers, C. (1996). Transforming growth factor b1
induces differentiation in human papillomavirus-positive keratino-
cytes. J. Virol. 70, 5437–5446.
Ozbun, M. A., and Meyers, C. (1997). Characterization of late gene
transcripts expressed during vegetative replication of human papil-
lomavirus type 31b. J. Virol. 71, 5161–5172.
zbun, M. A., and Meyers, C. (1998a). Temporal usage of multiple
promoters during the life cycle of human papillomavirus type 31b.
J. Virol. 72, 2715–2722.
zbun, M. A., and Meyers, C. (1998b). Human papillomavirus type 31b
E1 and E2 transcript expression correlates with vegetative viral
genome amplification. Virology 248, 218–230.
arkin, D. M., Pisani, P., and Ferlay, J. (1993). Estimates of the worldwide
incidence of eighteen major cancers. Int. J. Cancer 54, 594–606.
Pfister, H. (1987). Relationship of papillomaviruses to anogenital can-
cer. Obstet. Gynecol. Clin. North Am. 14, 349–361.
Pfister, H. (1990). “Papillomaviruses and Human Cancer.” CRC Press,
Boca Raton, FL.Rittner, K., Heilbronn, R., Kleinschmidt, J. A., and Sczakiel, G. (1992).
Adeno-associated virus type2-mediated inhibition of human immu-
nodeficiency virus type 1 (HIV-1) replication: Involvement of the
p78rep/p68rep and the HIV-1 long terminal repeat. J. Gen. Virol. 73,
2977–2981.
Schlehofer, J. R., Ehrbaar, M., and zur Hausen, H. (1986). Vaccinia,
herpes simplex, and carcinogen induced DNA amplification in a
human cell line and supported replication of a helper virus-depen-
dent parvovirus. Virology 152, 110–117.
Schmitt, J., Schlehofer, J. R., Mergener, K., Gissman, L., and zur Hausen,
H. (1989). Amplification of bovine papillomavirus DNA by N-methyl-
N-nitro-N-nitrosoquanidine, ultraviolet irradiation, or infection with
herpes simplex virus. Virology 172, 73–81.
Schoop, V. M., Mirancea, N., and Fusenig, N. E. (1999). Epidermal
organization and differentiation of HaCaT keratinocytes in organo-
typic coculture with human dermal fibroblasts. J. Invest. Dermatol.
112, 343–353.
Sil, A. K., Xin, P., and Hopper, J. E. (2000). Vectors allowing amplified
expression of the Saccharomyces cerevisiae Gal3p-Gal80p-Gal4p
transcription switch: Applications to galactose-regulated high-level
production of proteins. Protein Expression Purif. 18, 202–212.
Su, P.-F., Chiang, S.-Y., Wu, C.-W., and Wu, F. Y.-H. (2000). Adeno-
associated virus major Rep78 protein disrupts binding of TATA-
binding protein to the p97 promoter of human papillomavirus type 16.
J. Virol. 74, 2459–2465.
Syrjanen, L., Gissman, L., and Koss, L. G., Eds. (1987). “Papillomavi-
ruses and Human Disease.” Springer-Verlag, Berlin.
Tobiasch, E., Rabreau, M., Geletneky, K., Larue, Charles, S., Severin, F.,
Becker, N., and Schlehofer, J. R. (1994). Detection of adeno-associ-
ated virus DNA in human genital tissue and in material from spon-
taneous abortion. J. Med. Virol. 44, 215–222.
Walz, C., Deprez, A., Dupressoir, T., Durst, M., Rabreau, M., and Schle-
hofer, J. R. (1997). Interaction of human papillomavirus type 16 and
adeno-associated virus type 2 co-infecting human cervical cancer
epithelium. J. Gen. Virol. 78, 1441–1452.
Werness, B. A., Munger, K., and Howley, P. M. (1991). Role of the human
papillomavirus oncoproteins in transformation and carcinogenic pro-
gression. Import. Adv. Oncol. 3–18.
Zhan, D.-J., Santin, A. D., Parham, G. P., Li, C., Meyers, C., and Her-
monat, P. L. (1999). Binding of the human papillomavirus type 16 p97
promoter by the adeno-associated virus Rep78 major regulatory
protein correlates with inhibition. J. Biol. Chem. 274, 31619–31624.
zur Hausen, H. (1991). Viruses in human cancer. Science 254, 1167–
1173.
zur Hausen, H., and Schneider, A. (1987). The role of papillomaviruses
in human anogenital cancer. In “The Papovaviridae,” Vol. 2, “The
Papillomaviruses” (N. Salzman and P. M. Howley, Eds.), pp. 245–263.
Plenum, New York.
